A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients (2009)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; MACHADO, ALCYONE ARTIOLI - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Schools: FORP; FMRP
- DOI: 10.1038/tpj.2009.13
- Subjects: POLIMORFISMO; METALOPROTEINASES; SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA (TERAPIA); FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 9, n. 4, p. 265-273, 2009
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
DEMACQ, Caroline; VASCONCELLOS, Vivian B; MARCACCINI, Andréa Márcia; et al. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal, London, v. 9, n. 4, p. 265-273, 2009. DOI: 10.1038/tpj.2009.13. -
APA
Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Machado, A. A., & Santos, J. E. T. dos. (2009). A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal, 9( 4), 265-273. doi:10.1038/tpj.2009.13 -
NLM
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Machado AA, Santos JET dos. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal. 2009 ; 9( 4): 265-273. -
Vancouver
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Machado AA, Santos JET dos. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal. 2009 ; 9( 4): 265-273. - Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects
- Ativação pulmonar da enzima metaloproteinase (MMP)-9 durante embolia pulmonar aguda
- Nicotine accutely increases plasma MMP-9 activity
- Efeitos agudos da nicotina sobre a atividade da enzima matriz metaloproteinase (MMP)-9
- Effects of atorvastatin on plasma MMP-2 and MMP-9 activity in healthy volunteers
- Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- 'beta IND.1'-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy
- Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 MMP-9 activities
- Determinação de gelatinases no fluido gengival em pacientes sadios e com doença periodontal
Informações sobre o DOI: 10.1038/tpj.2009.13 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
